MRS-1220, with the CAS number 183721-15-5, is a chemical compound that belongs to the class of selective serotonin receptor antagonists. It is primarily known for its role in pharmacological research, particularly in the study of serotonin receptors and their implications in various neurological and psychiatric conditions. MRS-1220 exhibits high affinity for specific serotonin receptor subtypes, making it a valuable tool in understanding serotonin's role in the central nervous system. The compound is typically characterized by its ability to modulate neurotransmitter activity, which can influence mood, anxiety, and other behavioral responses. In laboratory settings, MRS-1220 is often utilized in assays to investigate receptor interactions and the effects of serotonin modulation. As with many research chemicals, safety and handling precautions are essential, as the compound may have specific toxicity profiles or require careful dosing in experimental applications. Overall, MRS-1220 serves as an important compound in the field of neuropharmacology.

mrs-1220

183721-15-5: N-(9-chloro-2-furan-2-yl[1,2,4]triazolo[1,5-c]quinazolin-5-yl)-2-phenylacetamide

MRS1220, a selective and potent antagonist for the human A3 adenosine receptor (hA3AR) with a dissociation constant (Ki) of 0.59 nM, exhibits therapeutic

CAS 183721-15-5: mrs-1220

MRS1220

Ref: TM-T23016

9-CHLORO-2-(2-FURANYL)-5-[(PHENYLACETY)AMINO][1,2,4]-TRIAZOLO[1,5-C] QUINAZOLINE

Ref: IN-DA00AEBM

MRS1220

Ref: 54-BUP01164

MRS 1220

Ref: 3D-FM30704